Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.
Reviewers:
(1) Sumit Mohan, Dental Institute, RIMS, India.
(2) Mehdi Ahmadinejad, Kerman University of Medical Sciences, kerman.
(3) Bindiya Sharma, RGPV, India.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 9.16/10
Average Peer review marks at publication stage: 9.5/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Sumit Mohan, India) | File 1 | NA
Stage 2 | Peer review report_2 (Mehdi Ahmadinejad, kerman) | File 1 | NA
Stage 2 | Peer review report_3 (Bindiya Sharma, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA